期刊文献+

NBD多肽促进成骨细胞分化的实验研究 被引量:2

NBD peptide promotes osteoblast differentiation
原文传递
导出
摘要 [目的]探讨核因子κB必需分子(NF-κB essential modulator,NEMO)结合的小分子多肽(NEMO bind-ing domain,NBD)通过阻断肿瘤坏死因子-α信号通路影响成骨细胞分化的作用及其分子机制。[方法]应用BMP-2体外诱导鼠肌源细胞C2C12向成骨细胞分化模型,外源添加TNF-α和/或BMP-2细胞因子培养,通过碱性磷酸酶(ALP)活性检测,瞬时转染和基因测定,研究NBD多肽对抗NF-κB活性和改善TNF-α抑制成骨细胞分化的过程。[结果]ALP染色显示NBD多肽能明显阻断TNF-α对C2C12向成骨细胞分化的抑制而促进其分化,荧光素酶活性测定显示TNF-α降低BMP-2活性从7.12倍到1.31倍,而NBD多肽使其恢复到6.7倍和mNBD肽恢复到1.4倍。[结论]TNF-α抑制成骨细胞分化的分子生物机制是通过激活NF-kB阻碍成骨细胞的分化。NBD多肽具有对抗NF-κB活性和改善TNF-α抑制成骨细胞分化过程的作用。 [ Objective ] To investigate the effect and molecular mechanism of NBD peptide on osteoblast differentiation. [ Method] The C2C12 ceils stimulated with BMP -2 were used as an in vitro model for studying osteoblast differentiation. Transi- ent transfection, lnciferase reporter activity assay and real-time RT-PCR were performed to study the effect of NBD peptide on os- teoblast differentiation. [ Result] TNF-α significantly reduced the ALP activities in a dose dependent manner in BMP2-induced C2C12 cells. TNF-α decreased the BMP-2 activity from 7.12 to 1.31 fold,and NBD peptide restored it back to 6.7 fold,while mNBD peptide left it at I. 4 fold. [ Conclusion] TNF-a inhibits osteoblast differentiation through the activation of NF-κB. Appli- cation of NBD peptide ameliorates this inhibitory effect. Key words:osteoblast differentiation, tumor necrosis factor-alpha, nuclear factor kappa B, NEMO Binding domain
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2011年第17期1463-1466,共4页 Orthopedic Journal of China
基金 国家自然科学基金资助项目 编号:30672133
关键词 成骨细胞分化 肿瘤坏死因子-Α 核转录因子-ΚB NBD多肽 osteoblast differentiation, tumor necrosis factor-alpha, nuclear factor kappa B, NEMO Binding domain
  • 相关文献

参考文献16

  • 1King GN,Cochran DL. Factors that modulate the effects of bone morphogenetic protein - induced periodont',d regeneration : a critical review [ J ]. J Periodontol,2002,73:925 - 936.
  • 2Young H E. Existence of reserve quiescent stem cells in adults. From amphibians to humans [ J ]. Curr Top Microbiol Immunol, 2004,280 : 71 -109.
  • 3Dai S, Hirayama T,Abbas S,et al. The IkappaB kinase (IKK) inhibitor, NEMO -binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis [ J ]. J Biol Chem, 2004,279 :37219 -37222.
  • 4Tsialogiannis E, Polyzois I, Tang QO, et al. Targeting bone morphogenetic protein antagonists:in vitro and in vivo evidence of their role in bone metabolism[ J ]. Expert Opin Ther Targets,2009,13:123 -137.
  • 5Canalis E, Economides AN, Gazzerro E, et al. Bone morphogenetic proteins, their antagonists, and the skeleton [ J ]. Endocr Rev, 2003,24 : 218 -235.
  • 6Korchlaskyi O, Dechering KJ, Sijbers AM, et al. Gene array analysis of bone morphogenetic protein type I receptor - induced osteoblast differentiation [ J ]. J Bone Miner Res,2003,18 : 1177 - 1185.
  • 7Boyle WJ, Simonet WS, Lacey DL, et al. Osteoclast differentiation and activation [ J ]. Nature, 2003,423 : 337 - 342.
  • 8Xiao YT, Xiang LX, Shao JZ, et al. Bone morphogenetic protein [ J ]. Biochem Biophys Res Commun,2007 ,362 :550 - 553.
  • 9Pande V, Ramos MJ. NF - kappa B in human disease : current inhibitors and prospects for de novo structure based design of inhibitors [ J ]. Curr Med Chem,2005,12:357 - 374.
  • 10Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation [ J ]. Nature, 2007,446 : 557 -561.

同被引文献9

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部